Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells.
Liu M, Dong Q, Chen B, Liu K, Zhao Z, Wang Y, Zhuang S, Han H, Shi X, Jin Z, Hui Y, Gu Y.
Liu M, et al. Among authors: jin z.
Br J Cancer. 2023 Oct;129(8):1339-1349. doi: 10.1038/s41416-023-02404-w. Epub 2023 Aug 24.
Br J Cancer. 2023.
PMID: 37620409
Free PMC article.